TechTakes

Gross, but I'm not shocked. IVF and prenatal genetics screening is big business, it was really only a matter of time until someone tried pulling this. As much as it shouldn't be the case, the 'line must go up' edict holds in the medical business too. I know some large lab services companies that are likely watching groups like this with great interest (but letting them take the risks first, which is smart because this is a con).

My hope is that someone squashes this and we keep screening limited to risks for severe developmental disorders (which, even still, is at least a little ethically problematic) and conditions that lower the probability of the pregnancy coming to term. But we'll see - there's gold in dem der embryos.